Clinical Trial Update: Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) [Phase 2, Phase 3]

View source ↗

Summary

This entry describes a randomized trial of sildenafil for pulmonary hypertension in patients with rheumatic valvular heart disease, spanning Phase 2 and Phase 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Rheumatic Valvular Heart Disease

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Sindh Institute of Cardiovascular Diseases | Conditions: Pulmonary Hypertension, Rheumatic Valvular Heart Disease | Phase 2, Phase 3 | Status: RECRUITING